| Owning ethical innovation: Claims about commercial wearable brain technologies IC McCall, C Lau, N Minielly, J Illes Neuron 102 (4), 728-731, 2019 | 62 | 2019 |
| Neuroenhancement at Work: Addressing the Ethical, Legal, and Social Implications V Dubljević, IC McCall, J Illes Organizational neuroethics, 87-103, 2020 | 19 | 2020 |
| Ethics of mobile phone surveys to monitor non-communicable disease risk factors in low-and middle-income countries: A global stakeholder survey J Ali, MJ DiStefano, I Coates McCall, DG Gibson, GM Al Kibria, GW Pariyo, ... Global public health 14 (8), 1167-1181, 2019 | 13 | 2019 |
| Peering into the mind? The ethics of consumer neuromonitoring devices IC McCall, A Wexler Developments in Neuroethics and Bioethics 3, 1-22, 2020 | 9 | 2020 |
| Readiness for first-in-human neuromodulatory interventions IC McCall, N Minielly, A Bethune, N Lipsman, PJ McDonald, J Illes Canadian Journal of Neurological Sciences 47 (6), 785-792, 2020 | 7 | 2020 |
| Regulatory oversights for implantable neurodevices PJ McDonald, C Lau, IC McCall, N Lipsman, J Illes The Lancet Neurology 18 (10), 913, 2019 | 4 | 2019 |
| Human flourishing or injustice? Social, political, and regulatory implications of cognitive enhancement IC McCall, V Dubljević The Routledge Handbook of the Ethics of Human Enhancement, 389-406, 2023 | 2 | 2023 |
| How public opinion can inform cognitive enhancement regulation IC McCall, T McIntosh, V Dubljević AJOB neuroscience 11 (4), 245-247, 2020 | 2 | 2020 |
| Advances in ethics for the neuroscience agenda IC McCall, V Dubljević Neurobiology of Brain Disorders, 1025-1045, 2023 | | 2023 |
| Regulatory oversight for DBS: Current framework for device recall in North America P Mc Donald, J Illes, C Lau, IC McCall Brain Stimulation: Basic, Translational, and Clinical Research in …, 2019 | | 2019 |
